142 related articles for article (PubMed ID: 6171686)
1. Antidysrhythmic and electrophysiological effects of a new antianginal agent, bepridil.
Kane KA; Winslow E
J Cardiovasc Pharmacol; 1980; 2(2):193-203. PubMed ID: 6171686
[TBL] [Abstract][Full Text] [Related]
2. Supraventricular antidysrhythmic and electrophysiological effects of bepridil, a new antianginal agent.
Winslow E; Kane KA
J Cardiovasc Pharmacol; 1981; 3(4):655-67. PubMed ID: 6167797
[TBL] [Abstract][Full Text] [Related]
3. Comparative antidysrhythmic profiles of bepridil, amiodarone and disopyramide in the guinea-pig and dog.
Labrid C; Leinot M; Beaughard M; Basiez M; Duchene-Marullaz P
Arch Int Pharmacodyn Ther; 1981 Jan; 249(1):87-97. PubMed ID: 6971633
[TBL] [Abstract][Full Text] [Related]
4. Comparative antiarrhythmic and electrophysiological effects of drugs known to inhibit calmodulin (TFP, W7 and bepridil).
Barron E; Marshall RJ; Martorana M; Winslow E
Br J Pharmacol; 1986 Nov; 89(3):603-12. PubMed ID: 3492234
[TBL] [Abstract][Full Text] [Related]
5. Comparative electrophysiological effects of disopyramide and bepridil on rabbit atrial, papillary, and Purkinje tissue: modification by reduced extracellular potassium.
Winslow E; Campbell JK; Marshall RJ
J Cardiovasc Pharmacol; 1986; 8(6):1208-16. PubMed ID: 2434748
[TBL] [Abstract][Full Text] [Related]
6. Effects of bepridil on transmembrane action potentials recorded from isolated canine cardiac tissues. Studies on normal and infarct-zone Purkinje fibres and ventricular muscle cells.
Dangman KH
Naunyn Schmiedebergs Arch Pharmacol; 1985 May; 329(3):326-32. PubMed ID: 3875041
[TBL] [Abstract][Full Text] [Related]
7. Effects of bepridil on the electrophysiological properties of guinea-pig ventricular muscles.
Anno T; Furuta T; Itho M; Kodama I; Toyama J; Yamada K
Br J Pharmacol; 1984 Apr; 81(4):589-97. PubMed ID: 6609738
[TBL] [Abstract][Full Text] [Related]
8. Effects of bepridil on the electrophysiologic properties of isolated canine and rabbit myocardial fibers.
Kato R; Singh BN
Am Heart J; 1986 Feb; 111(2):271-9. PubMed ID: 3484892
[TBL] [Abstract][Full Text] [Related]
9. The effects of prolonged oral administration of a new antidysrhythmic drug (Org 6001) on coronary artery ligation dysrhythmias in conscious and anesthetized rats.
Kane KA; Leprán I; McDonald FM; Parratt JR; Szekeres L
J Cardiovasc Pharmacol; 1980; 2(4):411-23. PubMed ID: 6156339
[TBL] [Abstract][Full Text] [Related]
10. BW A256C, a chemically novel class 1 antiarrhythmic agent. A comparison of in vitro and in vivo activity with other class 1 antiarrhythmic agents.
Allan G; Donoghue S; Follenfant MJ; Sawyer DA
Br J Pharmacol; 1986 Jun; 88(2):333-43. PubMed ID: 3730698
[TBL] [Abstract][Full Text] [Related]
11. The antiarrhythmic and cardiac electrophysiological effects of buprenorphine.
Boachie-Ansah G; Sitsapesan R; Kane KA; Parratt JR
Br J Pharmacol; 1989 Jul; 97(3):801-8. PubMed ID: 2758241
[TBL] [Abstract][Full Text] [Related]
12. The beneficial actions of bepridil in acute myocardial infarction in anaesthetized dogs.
Marshall RJ; Muir AW
Br J Pharmacol; 1981 Jun; 73(2):471-9. PubMed ID: 6786404
[TBL] [Abstract][Full Text] [Related]
13. Modification by hypoxia, hyperkalaemia and acidosis of the cardiac electrophysiological effects of a range of antiarrhythmic drugs.
Pacini DJ; Boachie-Ansah G; Kane KA
Br J Pharmacol; 1992 Nov; 107(3):665-70. PubMed ID: 1472965
[TBL] [Abstract][Full Text] [Related]
14. Electromechanical effects of bepridil on rabbit isolated hearts.
Anno T; Furuta T; Itoh M; Kodama I; Toyama J; Yamada K
Br J Pharmacol; 1984 Jan; 81(1):41-7. PubMed ID: 6608388
[TBL] [Abstract][Full Text] [Related]
15. Bepridil: a review of its pharmacology and clinical efficacy as an anti-anginal agent with anti-arrhythmic properties.
Alpert JS; Coumel P; Greeff K; Krikler DM; Remme WJ; Schönbaum E; Verduyn CW
Pharmatherapeutica; 1985; 4(4):195-222. PubMed ID: 2414784
[TBL] [Abstract][Full Text] [Related]
16. Effects of bepridil, a new antianginal agent, on ambulatory electrocardiography in human volunteers.
Duchêne-Marullaz P; Kantelip JP; Trolèse JF
J Cardiovasc Pharmacol; 1983; 5(3):506-10. PubMed ID: 6191153
[TBL] [Abstract][Full Text] [Related]
17. Comparative antidysrhythmic and haemodynamic effects of orally or intravenously administered mexiletine and ORG 6001 in the anaesthetized rat.
Marshall RJ; Muir AW; Winslow E
Br J Pharmacol; 1981 Oct; 74(2):381-8. PubMed ID: 7317687
[TBL] [Abstract][Full Text] [Related]
18. Bepridil blockade of Ca2+-dependent action potentials in vascular smooth muscle of dog coronary artery.
Harder DR; Sperelakis N
J Cardiovasc Pharmacol; 1981; 3(4):906-14. PubMed ID: 6167820
[TBL] [Abstract][Full Text] [Related]
19. Studies on the bradycardia induced by bepridil.
Beaughard M; Ferrier M; Labrid C; Lamar JC; Leboeuf J; Piris P
Br J Pharmacol; 1982 Feb; 75(2):293-300. PubMed ID: 6985297
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of antagonism of aconitine-induced dysrhythmias in mice as a method of detecting and assessing antidysrhythmic activity.
Winslow E
Br J Pharmacol; 1980; 71(2):615-22. PubMed ID: 7470765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
